Connect Little Connect Little
Risultati di ricerca
Mostra tutti i risultati
  • Iscriviti
    Registrati
    Iscriviti
    Cerca
    Night Mode

Cerca

Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie

  • Notizie
  • EXPLORE
  • Pagine
  • Gruppi
  • Events
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Articoli
  • Blogs
  • Utenti
  • Pagine
  • Gruppi
  • Events
  • Balaji Gaikwad ha aggiunto una foto Health
    2025-10-08 09:18:24 -
    Antibody Drug Conjugates Market Size And Forecast to 2033
    The Antibody-Drug Conjugates (ADC) market is experiencing significant growth, driven by the rising demand for targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs. As of 2025, the global ADC market is valued at over USD 8 billion, with projections estimating it will surpass USD 20 billion by 2030, fueled by...
    0 Commenti 0 condivisioni 3K Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Jim Raca ha aggiunto una foto Networking
    2026-05-06 11:17:48 -
    Antibody-Drug Conjugates (ADC) Market Size, Share & Growth Report 2034 | CAGR 13.5%
    The Global Antibody-Drug Conjugates (ADC) Market Report offers a comprehensive evaluation of the antibody-drug conjugates industry, delivering valuable insights into business strategies, current market trends, and both qualitative and quantitative assessments. The study provides an in-depth analysis of critical market aspects, including key growth drivers, restraints, opportunities, risks, and...
    0 Commenti 0 condivisioni 268 Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
  • Onkar Dhakane ha aggiunto una foto Networking
    2026-01-22 19:54:52 -
    ADC Contract Manufacturing Market Experiencing Rapid Growth
    The Antibody Drug Conjugate (ADC) contract manufacturing market is at the forefront of the precision medicine revolution. Known as "biological missiles," ADCs combine the targeting specificity of monoclonal antibodies with the cell-killing potency of cytotoxic payloads. Because the production of these therapies requires a complex fusion of biologic manufacturing and high-potency...
    0 Commenti 0 condivisioni 1K Views 0 Anteprima
    Effettua l'accesso per mettere mi piace, condividere e commentare!
© 2026 Connect Little Italiano
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termini e Condizioni Privacy Contattaci Elenco